Infectious disease patent intelligence

US 8232275

2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8221737

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8222203

Macrocyclic oximyl hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8216594

Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

The Regents of the University of California · Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8211891

Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8202889

Inhibitors of bacterial IMPDH

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8202844

Indole antiviral compositions and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8198042

CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8192720

Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases

BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8193152

Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

The Board of Regents of the University of Texas System · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8187872

Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein

IMMUNE DESIGN CORP. · Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8178531

Antiviral agents

Enanta Pharmaceuticals, Inc. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8173673

Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof

Julius-Maximilians-Universitat Wurzburg · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168195

Vaccines against Escherichia coli O157 infection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8168604

Antisense antiviral compounds and methods for treating a filovirus infection

The United States of America as represented by the Army Medical Research and Material Command · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8163297

Live attenuated aldolase-negative bacterial vaccine

Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8163703

Hepatitis C therapies

BioCryst Pharmaceuticals, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8163893

Pseudotyped retroviral vectors and methods of use thereof

The Regents of the University of California · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8158677

Treatment of viral infections by modulation of host cell metabolic pathways

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8158675

Compounds and methods for the treatment or prevention of Flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8153116

Use of conditional plasmodium strains lacking an essential gene in malaria vaccination

UNIVERSITY OF CONNECTICUT · Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8147840

Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8148352

Antimicrobial therapy for bacterial infections

The Regents of the University of California · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8137960

Bovine adeno-associated viral (BAAV) vector and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8133496

Compositions and methods for diagnosing and treating urinary tract infections

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8128921

Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination

UNIVERSITY OF CONNECTICUT · Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8124592

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8124109

Vault compositions for immunization against chlamydia genital infection

The Regents of the University of California · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8124584

Macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8124110

Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species

The Regents of the University of California · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8110192

Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8105607

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

The Regents of the University of California · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8106027

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8105609

Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8106026

Development of a preventive vaccine for filovirus infection in primates

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8092812

Methods and compositions for immunization against chlamydial infection and disease

The Board of Regents of the University of Texas System · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088729

Anti-viral griffithsin compounds, compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8076372

Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

The Government of the United States · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8076100

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8076099

Biomarkers of Francisella infection

The Board of Regents of the University of Texas System · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071107

Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins

The Regents of the University of California · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067202

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044185

Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039001

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030307

Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8029809

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8025891

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

The Regents of the University of California · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8021671

Pro-apoptotic bacterial vaccines to enhance cellular immune responses

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)